Huge Canadian trial backs cardiac resynchronization therapyCombined ICD-CRT device cuts mortality and heart failure hospitalizations Pharmacy BP screening lowers hospitalizationsOntario’s Cardiovascular Health Awareness Program targeted community-dwelling seniors Atrial fibrillation admissions lack rhyme or reason But ER doctors pick the right patients to admit despite ‘no tools and no rules’ Cardiac imaging linked to cancer Study supports continued efforts to lower patients’ exposure to ionizing radiation Chest closure aid is just super Sternotomy patients experience less pain and disability when ‘Kryptonite’ adhesive is used European score yields mixed results in Canadian trial Guidelines highlight cutting-edge AF treatments Role of recently approved drugs outlined in new atrial fibrillation recommendations Oral contraceptives may stiffen the arteries Pradax approved for stroke prevention in atrial fibrillation Oral capsules now indicated for prevention of stroke and systemic embolism in patients with atrial fibrillation. New standard declared for high-risk valve replacement Practice Issues: Adverse Reactions - Cranberry juice–warfarin interaction Recent analysis looks at evidence that implicated an interaction between cranberry juice and warfarin. Meridia withdrawn from Canadian market Withdrawal follows study suggesting risk of serious cardiovascular events when drug used in heart disease patients. First Previous 72 73 74 75 76 Next Last
